FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. EPS 2020–2025
FibroGen, Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- FibroGen, Inc. eps for the quarter ending March 31, 2026 was $3.76, a 400.80% decrease year-over-year.
- FibroGen, Inc. annual eps for 2025 was $45.37, a 478.08% decrease from 2024.
- FibroGen, Inc. annual eps for 2024 was $12.00, a 310.96% increase from 2023.
- FibroGen, Inc. annual eps for 2023 was $2.92, a 7.01% decrease from 2022.
- FibroGen, Inc. annual eps for 2022 was $3.14.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
FibroGen, Inc. EPS — FAQ
FibroGen, Inc. (KYNB) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is FibroGen, Inc.'s eps?
FibroGen, Inc. (KYNB) reported eps of $45.37 for fiscal 2025.
Where can I see KYNB's eps history?
The chart and table above show FibroGen, Inc.'s eps by year and by quarter, including the growth rate.